OP0271 INCIDENCE OF PSORIATIC ARTHRITIS AND PREVALENCE OF UNDIAGNOSED CASES IN A UK PRIMARY CARE POPULATION FOLLOWED PROSPECTIVELY FOR 2 YEARS - RESULTS FROM THE TUDOR RANDOMIZED CLINICAL TRIAL

Neil McHugh(University of Bath), Sarah Brown(University of Leeds), Laura Bojke(University of York), Philip Helliwell(University of Leeds), Michael R. Ransom(Brigham Young University), Jon Packham(University of Nottingham), Laura C. Coates(Nuffield Orthopaedic Centre), William Tillett(Royal United Hospital Bath NHS Trust), Claire Davies(University of Leeds), Eldon Spackman(Alberta Health Services)
Annals of the Rheumatic Diseases
June 1, 2023
10.1136/annrheumdis-2023-eular.199
Cited by 1

Related Papers

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis
|Arthritis & Rheumatology|2016|904
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
|The Lancet|2010|640
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
|Nature Reviews Rheumatology|2022|575
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
|The Lancet|2015|477
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
|The Lancet Oncology|2013|392